Rezultaty - Joshua Hoenisch

  • Rezultaty 1 - 2 Rezultaty od 2
Redukuj rezultaty
  1. 1
    Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target

    Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target od Marta Llauradó Fernández, Amy Dawson, Joshua Hoenisch, Hannah Kim, Sylvia Bamford, Clara Salamanca, Gabriel E. DiMattia, Trevor G. Shepherd, Mattia Cremona, Bryan T. Hennessy, Shawn Anderson, Stanislav Volik, Colin C. Collins, David G. Huntsman, Mark Carey

    Wydane 2019
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  2. 2
    FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma

    FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous car... od Y Leung, Marta Llauradó Fernández, Anna Cameron, Annalyn Da-Anoy, Linda S. Cook, Joshua Hoenisch, Chanel Ghesquiere, Stéphanie Gaillard, J Schmid, Amy Dawson, Madison Bittner, Hannah Kim, Nelson K.Y. Wong, Gurdial Dhillion, Anna V. Tinker, Mark Carey, Martin Köbel

    Wydane 2025
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:

Narzędzie wyszukiwania: